Dietary Supplements

Combined intravenous bolus amino acid supplementation and mobilization on early muscle loss in critically ill adults: A randomized controlled trial.

TL;DR

A short-duration combined intervention of intravenous bolus amino acids and cycle ergometry, limited to the acute phase of critical illness, did not reduce muscle loss or improve muscle quality, strength, or physical capability.

Key Findings

Muscle loss occurred significantly over time in critically ill patients regardless of intervention group.

  • Primary co-outcomes were changes in vastus lateralis myofiber cross-sectional area (from biopsies) and ultrasound-derived rectus femoris cross-sectional area
  • Measurements were taken between preintervention (day 2) and postintervention (day 8) time points
  • Biopsy outcome: P = 0.01; ultrasound outcome: P < 0.001
  • No significant differences between intervention and standard care groups for either primary outcome

The intervention group received significantly more protein per day than the standard care group.

  • Standard of care participants received 1.23 ± 0.18 g/kg/day protein
  • Intervention participants received 1.57 ± 0.27 g/kg/day protein total
  • The intravenous amino acid supplement contributed 0.37 ± 0.05 g/kg/day of the intervention group's total protein intake
  • Both groups received standard care nutrition and mobilization as a baseline

No significant differences between groups were observed in any secondary outcomes.

  • Secondary outcomes assessed included protein-to-DNA ratio, muscle echogenicity, whole-body phase angle, muscle strength (Medical Research Council sum score), and physical capability (6-min walk test)
  • No significant between-group differences were found for any of these measures
  • Analyses were conducted using mixed-model analysis of variance and least significant difference testing

The study enrolled 50 critically ill adult patients who were predominantly young and male.

  • 50 patients were included in the randomized parallel-group trial
  • 90% of participants were male
  • Mean age was 37 ± 12 years
  • Patients were admitted to the surgical intensive care unit of a tertiary hospital
  • The intervention was administered starting on days 3-4 for a mean of 6 days

The combined intervention consisted of a daily intravenous amino acid bolus paired with 45 minutes of cycle ergometry during the acute phase of critical illness.

  • Intervention began on days 3-4 of ICU admission
  • The mean intervention duration was 6 days
  • Cycle ergometry sessions lasted 45 minutes
  • The intervention was delivered on top of standard care nutrition and mobilization
  • The study used a randomized parallel-group design

Have a question about this study?

Citation

Veldsman L, Richards G, Nel D, Kohn T, Blaauw R. (2026). Combined intravenous bolus amino acid supplementation and mobilization on early muscle loss in critically ill adults: A randomized controlled trial.. JPEN. Journal of parenteral and enteral nutrition. https://doi.org/10.1002/jpen.70041